Publications by authors named "Ana Torvisco Gomez"

Electrophilic fluorination of an exocyclic methoxymethylene enol ether derived from N-tert-butyloxycarbonyl-1,5-dideoxy-1,5-imino-3,4-O-isopropylidene-D-erythro-pent-2-ulose (11) provided the 5-fluoro derivative of the powerful β-galactosidase inhibitor 4-epi-isofagomine (8). This structural alteration, in combination with N-alkylation, led to considerably improved α-galactosidase selectivity. New compounds may serve as leads en route to new pharmacological chaperones for Fabry's disease.

View Article and Find Full Text PDF

A series of previously unknown bridgehead-functionalized bicyclo[2.2.2]octasilanes, MeSi-SiMe-X, X-SiMe-X, and X-SiMe-Y [X, Y = -SiMe Ph ( = 1, 2) (, , ), -SiMeFc (Fc = ferrocenyl) (, , , ), -COR (R = Me, Bu) (, , ), COOMe (), COOH ()], have been prepared by the reaction of the silanides MeSi-SiMeK or KSiMeK with proper electrophiles and fully characterized.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Ana Torvisco Gomez"

  • - Ana Torvisco Gomez's research primarily focuses on the synthesis and functionalization of novel compounds that have potential therapeutic applications, particularly in the field of enzyme inhibition related to genetic disorders.
  • - One significant study investigates 5-fluoro derivatives of 4-epi-isofagomine, demonstrating their enhanced selectivity as D-galactosidase inhibitors, which could be important in treating conditions such as GM1-gangliosidosis and Fabry's disease.
  • - Another area of her research involves the development of bridgehead-functionalized permethylbicyclo[2.2.2]octasilanes, contributing to the understanding of organosilicon chemistry and expanding the toolkit for synthetic organic chemistry.